challenges that appear on the homepage AND closed page.
Multi-targeting Drug DREAM Challenge
Open October 5, 2017 - February 26, 2018 (Closed)
This challenge seeks to diversify the methods used for rational design of drugs with multiple target proteins. Participants predict compounds active against two medically-relevant sets of targets, with predictions validated by commercial lab testing.
NCI-CPTAC DREAM Proteogenomics Challenge
This challenge will use public and novel proteogenomic data generated by the Clinical Proteomic Tumor Analysis Consortium (CPTAC) to benchmark an understanding of the interfaces between different layers of information in a population of cancer cells.